Gill Capital Partners’s NeoGenomics NEO Stock Holding History

Gill Capital Partners’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.03K	Hold	345	–	–	﹤0.01%	509
2026 Q1	$2.56K	Buy	+345	New	+$3.63K	﹤0.01%	539

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Gill Capital Partners's NEO Position: Q2 2026 in Review

Gill Capital Partners held its NeoGenomics (NEO) position steady in Q2 2026 at 345 shares worth $5.03K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Gill Capital Partners first reported a position in NEO in Q1 2026 and has held it in 2 quarters since. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Gill Capital Partners held 345 shares of NeoGenomics worth $5.03K as of Q2 2026.
Gill Capital Partners left its NeoGenomics share count unchanged in Q2 2026.
NeoGenomics made up ﹤0.01% of Gill Capital Partners's portfolio in Q2 2026, its #509 holding.
Gill Capital Partners first reported a position in NeoGenomics in Q1 2026 and has held it in 2 quarters since.
267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.